Stockholders are urged not to place undue reliance on forwardlooking statements which speak only102023 805 PM US Food and Drug Administration Approves BioMarins VOXZOGO vosoritide for Children Under 5 Years with Achondroplasia  Oct 20  httpsinvestorsbiomarincom20231020USFoodandDrugAdministrationApprovesBioMarinsVOXZOGORvosoritideforChildrenUnder5Yearswith 1011Navigate Our MotivationAbout Our Historyas of the date hereof